Concepedia

Lionel Renaud

LR

Statistics

Publications

4

Citations

190

H-Index

4

Active since

2019

Affiliations

Paris Biotech Santé(Current)

Inserm

Institut Galien Paris-Saclay

Lionel Renaud is an author at Paris Biotech Santé specializing in pharmacokinetics, pharmacology, and pharmacokinetics of monoclonal antibodies.

Publications per year

2019–2024

4

Publications

4

Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT017, an Antiplatelet GPVI (Glycoprotein VI) Fab

Christine Voors‐Pette, Kristell Lebozec, Peter Dogterom et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2019 · 116 citations · Full text

, , +8

Population Pharmacokinetic/Pharmacodynamic Modeling of Glenzocimab (ACT017) a Glycoprotein VI Inhibitor of Collagen‐Induced Platelet Aggregation

Lionel Renaud, Kristell Lebozec, Christine Voors‐Pette et al. · The Journal of Clinical Pharmacology · 2020 · 35 citations · Full text

, , +17

Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4

Katherine Griffiths, Uli Binder, William McDowell et al. · mAbs · 2019 · 28 citations · Full text

, , +17

Prediction of Cardiac <scp>ATTR</scp> Depletion by <scp>NI006</scp> (<scp>ALXN2220</scp>) Using Mechanistic <scp>PK</scp>/<scp>PD</scp> Modeling

Aubin Michalon, Lionel Renaud, Matthias Macháček et al. · Clinical Pharmacology & Therapeutics · 2024 · 11 citations · Full text

, , +17

1–4 of 4